Utility of coronary artery calcium scoring in low-risk patients: The Multi-Ethnic Study of Atherosclerosis (MESA)
American Journal of Preventive Cardiology · 2025-12 · 24 · 101329
DOI: 10.1016/j.ajpc.2025.101329 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2025-12. Verfasst von Jonathan R Davis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Background
Guidelines recommend consideration of coronary artery calcium (CAC) scoring in intermediate atherosclerotic cardiovascular disease (ASCVD) risk patients, but its utility in lower-risk individuals is less clear.
Methods
Data from 6712 participants from MESA was used with 10-year ASCVD risk defined by the pooled cohort equations (PCE) and AHA PREVENT equations. The association between CAC, CHD and ASCVD risk was evaluated using Cox proportional hazard models. Risk prediction improvement was evaluated using Harrell's C-index and net reclassification improvement (NRI).
Results
Amongst all participants (mean age 62.2 ± 10.2 years, 52.8 % women), the ASCVD event rate per 1000 person years was 14.3 vs. 4.1 with and without CAC over a median of 16.7 years. CAC score was most strongly associated with increased ASCVD risk in low and borderline-risk individuals (HR 1.35, 95 % CI 1.22-1.50 and 1.30, 1.16-1.46). Among these individuals, addition of the Agatston score to the PCE improved the C-index (SE) for ASCVD from 0.593(0.029) to 0.640(0.031) and 0.558(0.037) to 0.663(0.036), respectively. Category-free NRI was also significant in low (0.3268, 95 % CI 0.0960-0.5408) and borderline (0.4283, 0.2319-0.7332) risk individuals with similar results using the AHA PREVENT equations. Using a statin eligibility threshold of 7.5 %, the addition of CAC correctly reclassified a net of 10.1 % of low/borderline risk individuals vs the PCE and 16.7 % vs. PREVENT.
Conclusions
CAC is associated with increased ASCVD risk in lower-risk individuals. The addition of CAC scoring to the PCE and AHA PREVENT equations improved risk prediction, suggesting potential utility in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA.
- Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Medicine, University of California San Diego, La Jolla, CA, USA.
- Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Division of Preventive Medicine, Department of Family Medicine, University of California, San Diego, La Jolla, CA, USA.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Davis, J. R., Razavi, A. C., Ellberg, C. C., Blaha, M. J., Criqui, M. H., & Bhatia, H. S. (2025). Utility of coronary artery calcium scoring in low-risk patients: The Multi-Ethnic Study of Atherosclerosis (MESA). American Journal of Preventive Cardiology, 24, 101329. https://doi.org/10.1016/j.ajpc.2025.101329
Vancouver
Davis JR, Razavi AC, Ellberg CC, Blaha MJ, Criqui MH, Bhatia HS. Utility of coronary artery calcium scoring in low-risk patients: The Multi-Ethnic Study of Atherosclerosis (MESA). American Journal of Preventive Cardiology. 2025;24:101329. doi:10.1016/j.ajpc.2025.101329
BibTeX
@article{Davis2025,
author = {Davis, Jonathan R and Razavi, Alexander C and Ellberg, Charlotte C and Blaha, Michael J and Criqui, Michael H and Bhatia, Harpreet S},
title = {Utility of coronary artery calcium scoring in low-risk patients: The Multi-Ethnic Study of Atherosclerosis (MESA)},
journal = {American Journal of Preventive Cardiology},
year = {2025},
volume = {24},
pages = {101329},
doi = {10.1016/j.ajpc.2025.101329}
}
EUVIMED